Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.8 USD | -0.65% | -2.61% | +202.66% |
May. 31 | Jasper Therapeutics, Inc. to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024 | CI |
May. 20 | Transcript : Jasper Therapeutics, Inc. - Special Call |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
JASPER THERAPEUTICS, INC. | Other Pharmaceuticals | -0.29% | -2.61% | +202.66% | +47.41% | - | 361M |
Technical Rankings Surperformance
- Stock Market
- Equities
- JSPR Stock
- Charts Jasper Therapeutics, Inc.
- Comparison Chart